- Krystalyn Weaver / GMU Antonin Scalia School of Law
- Luis D. Barry / Perez Alati, Grondona, Benites & Arntsen (Argentina)
- Xi Liao / Linklaters (Beijing)
- Anne Robert / Sidley Austin LLP
Presented by the Health Care and Pharmaceuticals Committee.
Join us for the next installment of the International Antitrust Recent Developments Initiative, a series of semiannual programs on antitrust developments in health care and pharmaceuticals outside of the U.S. The program covers enforcement developments in merger control, restrictive agreements, and abuse of dominance in the EU, Asia, and South America from December 2019 through April 2020. This presentation aims to provide in-house and external antitrust practitioners with an overview of major recent developments.